Use the hyperlinks, where available to access additional clinical trial information.
European Low and Intermediate Risk Neuroblastoma Protocol
Other Non-Commercial Sponsor
Instituto de Investigacion Sanitaria La Fe
This trial groups together into a single protocol the treatment of all patients with "non high risk" neuroblastoma, with stratification into two groups: low risk and intermediate risk. Treatment may include chemotherapy, surgery and radiotherapy, or a combination of these treatments, depending on individual cases.